Get the Stockscreener App
0.6188
0.13%
0.0008
After Hours:
.61
-0.0088
-1.42%
Klotho Neurosciences Inc stock is traded at $0.6188, with a volume of 850.75K.
It is up +0.13% in the last 24 hours and up +4.85% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.618
Open:
$0.6
24h Volume:
850.75K
Relative Volume:
0.38
Market Cap:
$37.98M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-1.3588
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
+4.14%
1M Performance:
+4.85%
6M Performance:
+255.63%
1Y Performance:
+23.81%
1-Day Range:
$0.581
$0.6451
1-Week Range:
$0.5251
$0.665
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.6188 | 37.93M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
How institutional ownership impacts Klotho Neurosciences Inc. stockOil Prices & Fast Entry and Exit Trade Plans - newser.com
Will a bounce in Klotho Neurosciences Inc. Equity Warrant offer an exitQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Momentum divergence signals in Klotho Neurosciences Inc. Equity Warrant chartTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Will Klotho Neurosciences Inc. Equity Warrant stock sustain high P E ratiosShare Buyback & Weekly Watchlist for Consistent Profits - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock attractive after correctionWeekly Trend Summary & Technical Entry and Exit Tips - newser.com
Is now a turning point for Klotho Neurosciences Inc.2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Long term hold vs stop loss in Klotho Neurosciences Inc.Market Sentiment Review & Community Trade Idea Sharing - newser.com
Analyzing recovery setups for Klotho Neurosciences Inc. Equity Warrant investorsPortfolio Risk Summary & Entry and Exit Point Strategies - newser.com
Is Klotho Neurosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Will Klotho Neurosciences Inc. stock benefit from commodity pricesWeekly Stock Analysis & Community Consensus Picks - newser.com
Can technical indicators confirm Klotho Neurosciences Inc. Equity Warrant’s reversal2025 Analyst Calls & Growth Oriented Trading Recommendations - newser.com
Klotho Neurosciences Inc. stock volume spike explainedJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
Klotho Neurosciences to acquire select assets from Turn Biotechnologies - MSN
Why Klotho Neurosciences Inc. stock appeals to analystsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Published on: 2025-10-10 05:36:46 - newser.com
Published on: 2025-10-10 04:03:17 - newser.com
Historical volatility pattern of Klotho Neurosciences Inc. visualizedWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Is Klotho Neurosciences Inc. trending in predictive chart modelsQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Klotho Neurosciences Announces Expiration of Letter of Intent - Eastern Progress
2.1B aging population by 2050: Klotho Lets LOI with Turn Expire, Refocuses on Klotho Pipeline - Stock Titan
Earnings visualization tools for Klotho Neurosciences Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
What’s next for Klotho Neurosciences Inc. stock priceExit Point & AI Driven Stock Movement Reports - newser.com
Why Klotho Neurosciences Inc. is moving todayPortfolio Gains Report & Fast Entry Momentum Trade Alerts - newser.com
Will Klotho Neurosciences Inc. stock recover after recent dropJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
How strong is Klotho Neurosciences Inc. Equity Warrant stock balance sheet2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Combining price and volume data for Klotho Neurosciences Inc.Quarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Klotho Neurosciences Inc. Equity WarrantProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Visual trend scoring systems applied to Klotho Neurosciences Inc.2025 Price Targets & AI Driven Stock Movement Reports - newser.com
How to use a screener to detect Klotho Neurosciences Inc. breakoutsAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Is Klotho Neurosciences Inc. Equity Warrant forming a reversal pattern2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Reversal indicators forming on Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Patterns & Stock Portfolio Risk Management - newser.com
Can swing trading help recover from Klotho Neurosciences Inc. lossesJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):